Sareum Hldgs Plc (SAR)

Currency in GBP
16.5000
0.0000(0.00%)
Real-time Data·
SAR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SAR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.010016.5000
52 wk Range
11.000032.0000
Key Statistics
Bid/Ask
16.00 / 17.00
Prev. Close
16.5
Open
16.01
Day's Range
16.01-16.5
52 wk Range
11-32
Volume
22.49K
Average Volume (3m)
288.61K
1-Year Change
-45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SAR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Sareum Hldgs Plc Company Profile

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company’s lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also involves in developing SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Checkpoint kinase 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.

Compare SAR to Peers and Sector

Metrics to compare
SAR
Peers
Sector
Relationship
P/E Ratio
−7.7x−0.7x−0.5x
PEG Ratio
−0.160.000.00
Price/Book
5.0x1.8x2.6x
Price / LTM Sales
-2.0x3.3x
Upside (Analyst Target)
-70.7%43.3%
Fair Value Upside
Unlock−4.8%6.9%Unlock

Earnings

Latest Release
Mar 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SAR Income Statement

FAQ

What Stock Exchange Does Sareum Trade On?

Sareum is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Sareum?

The stock symbol for Sareum is "SAR."

What Is the Sareum Market Cap?

As of today, Sareum market cap is 22.34M.

What Is Sareum's Earnings Per Share (TTM)?

The Sareum EPS (TTM) is -0.03.

When Is the Next Sareum Earnings Date?

Sareum will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is SAR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sareum Stock Split?

Sareum has split 1 times.

How Many Employees Does Sareum Have?

Sareum has 5 employees.

What is the current trading status of Sareum (SAR)?

As of 11 Aug 2025, Sareum (SAR) is trading at a price of 16.50, with a previous close of 16.50. The stock has fluctuated within a day range of 16.01 to 16.50, while its 52-week range spans from 11.00 to 32.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.